[Federal Register Volume 83, Number 39 (Tuesday, February 27, 2018)]
[Notices]
[Page 8492]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-03897]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory 
Board (DTAB) will meet in person and via web conference on March 20, 
2018, from 10:00 a.m. to 3:00 p.m. EDT, and March 21, 2018 from 10:00 
a.m. to 2:00 p.m. EDT.
    The Board will meet in open session on March 20, 2018, from 10:00 
a.m. to 1:00 p.m., to provide updates on the Mandatory Guidelines for 
Federal Workplace Drug Testing Programs, hear from our federal partners 
and early observations from the synthetic opioid testing 
implementation, review research data on a marijuana vaping study, and a 
brief update on the Medical Review Officer (MRO) Guidance Manual and 
2018 MRO Guidance Manual Case Studies.
    The board will meet in closed session on March 20, 2018, from 2:00 
p.m. to 3:00 p.m. EDT and on March 21, 2018, from 10:00 a.m. to 2:00 
p.m. EDT to discuss the proposed Mandatory Guidelines for Federal 
Workplace Drug Testing Programs (oral fluid), and the Mandatory 
Guidelines for Federal Workplace Drug Testing Programs (hair specimen). 
Therefore, these portions of the meeting are closed to the public as 
determined by the Assistant Secretary, SAMHSA, in accordance with 5 
U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, Section 10(d).
    Meeting registration information can be completed at http://snacregister.samhsa.gov/MeetingList.aspx. Web conference and call 
information will be sent after completing registration. Meeting 
information and a roster of DTAB members may be obtained by accessing 
the SAMHSA Advisory Committees website, http://www.samhsa.gov/about-us/advisory-councils/drug-testing-advisory-board-dtab or by contacting the 
Designated Federal Officer, CAPT Sean J. Belouin, USPHS.
    Committee Name: Substance Abuse and Mental Health Services 
Administration's Center for Substance Abuse Prevention Drug Testing 
Advisory Board.
    Dates/Time/Type:
    March 20, 2018, from 10:00 a.m. to 1:00 p.m., EDT: Open.
    March 20, 2018, from 2:00 p.m. to 3:00 p.m., EDT: Closed.
    March 21, 2018, from 10:00 a.m. to 2:00 p.m., EDT: Closed.
    Place: Parklawn Building, Room 5A03, 5600 Fishers Lane, Rockville, 
Maryland 20857.
    Contact: CAPT Sean J. Belouin, USPHS, Senior Pharmacology and 
Regulatory Policy Advisor, Division of Workplace Programs, 5600 Fishers 
Lane, Room 16N06D, Rockville, Maryland 20857, Telephone: (240) 276-
2600, Email: [email protected].

Charles LoDico,
Chemist.
[FR Doc. 2018-03897 Filed 2-26-18; 8:45 am]
 BILLING CODE 4162-20-P